This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Community Health (CYH)

Tipranks - Tipranks - Thu Apr 23, 6:50AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eli Lilly & Co (LLY), Exelixis (EXEL) and Community Health (CYH).

Claim 30% Off TipRanks

Eli Lilly & Co (LLY)

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co today. The company’s shares closed last Tuesday at $903.02.

According to TipRanks.com, Devarakonda is a 5-star analyst with an average return of 17.7% and a 57.5% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Madrigal Pharmaceuticals, and Protagonist Therapeutics. ;'>

Currently, the analyst consensus on Eli Lilly & Co is a Strong Buy with an average price target of $1247.71, a 37.1% upside from current levels. In a report issued on April 7, TipRanks – xAI also upgraded the stock to Buy with a $1038.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Exelixis (EXEL)

Goldman Sachs analyst Paul Choi maintained a Buy rating on Exelixis yesterday and set a price target of $50.00. The company’s shares closed last Tuesday at $45.89.

According to TipRanks.com, Choi is a 4-star analyst with an average return of 8.8% and a 55.4% success rate. Choi covers the Healthcare sector, focusing on stocks such as Phathom Pharmaceuticals, Corvus Pharmaceuticals, and Soleno Therapeutics. ;'>

Exelixis has an analyst consensus of Moderate Buy, with a price target consensus of $46.45, representing a 5.1% upside. In a report issued on April 14, William Blair also maintained a Buy rating on the stock.

Community Health (CYH)

Truist Financial analyst David S Macdonald reiterated a Hold rating on Community Health today. The company’s shares closed last Tuesday at $3.10, close to its 52-week low of $2.53.

According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 9.8% and a 57.0% success rate. Macdonald covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, Concentra Group Holdings Parent, Inc., and Ardent Health Partners, Inc. ;'>

Community Health has an analyst consensus of Hold, with a price target consensus of $3.55, an 11.6% upside from current levels. In a report released today, TipRanks – xAI also reiterated a Hold rating on the stock with a $3.50 price target.

Read More on LLY:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).